Bird flu: more drugs please - May 15, 2008
A study in this week’s Nature shows that the H5N1 strain of bird flu seems to be developing drug resistance [wrong link fixed]. This, say the authors, means stockpiles designed to be used in a pandemic need to be made up of more than one drug.
Researchers led by Steve Gamblin, of the National Institute for Medical Research in London, used X-ray crystallography to determine the structure of mutants of H5N1. They found that the drug oseltamivir (Tamiflu) was not very useful against them, but zanamivir (Relenza) was still good. (Needless to say, Relenza’s producer Glaxo is pretty happy.)
“In order not to be outflanked by the virus, it will be necessary to have stocks of both existing drugs,” says Gamblin (BBC). “There is a huge imperative to develop further drugs and it is likely a future pandemic will need to be tackled using a three or four-pronged approach, much as we tackle HIV today.”


A US Senate committee is to hold hearings into a controversial experiment that involved spreading sewage sludge onto lawns in poor, black neighbourhoods.
In a remarkable victory for common sense a US government funded health website is allowing users to search for articles about ‘abortion’.
Dextre, the Canadian space agency’s new robot, is meant to be helping construct the ISS. Instead it’s
Both South Korea and Japan have impounded suspect shipments of Italian mozzarella after finding high levels of dioxins in the tasty dairy product.
A skin secretion from a bizarre shrinking frog could one day help people with diabetes, according to Yasser Abdel-Wahab.